DEVELOPMENT OF METOCLOPRAMIDE HYDROCHLORIDE IN SITU GEL: NASAL DELIVERY AND PHARMACOKINETICS IN NEW ZEALAND RABBITS

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 4

Abstract

Objective: Systemic bioavailability of metoclopramide hydrochloride (MCH) is 32–80% by oral route. The study was targeted to develop in situ gel of MCH for nasal delivery and to study its pharmacokinetics in healthy rabbits. Pre-systemic metabolism can be overcome. Methods: Poloxamer 407 (P407) aqueous solutions were prepared by cold method. In 32 factorial design, independent variables were Carbopol 934P and polyethylene glycol 6000 (PEG 6000), and dependent responses were gelation temperature, mucoadhesive strength, and drug release. A Pharmacokinetic study was carried out in New Zealand rabbits. The optimized in situ gel (1 mg/ml) was compared with marketed Reglan® (2 mg/2 ml) injection. Area under the curve (AUC), Cmax, and Tmax were estimated. Results: F2 was an optimized formulation. The study showed that P407 solutions formed a gel at nasal temperature 34°C having mucoadhesive strength 806.12±3.45 dyne/cm2. MCH release was found to be 93.74±1.31% within 6 h. Histopathological examination of formulation F2 exhibited safety to the nasal mucosa. The pH of formulations was 5.1±0.1 to 5.6±0.1 in the range of pH of nasal cavity. Plasma samples were analyzed by liquid chromatography/mass spectroscopy (LC/MS). The area under curve AUC0-4 for in situ gel by nasal route was 2716±4.617 ng/h/ml and for marketed solution by intravenous route was 2874±1.0816 ng/h/ml. These were comparable. Nasal bioavailability was found 94.50% from in situ gel. Duration of action was longer, and steady-state concentration was found for in situ gel. Conclusion: In situ gel was capable to release MCH in systemic circulation. In vivo study in rabbits has proved the improved bioavailability of MCH administered nasally. The optimized gel preparation was found to be promising for improved bioavailability.

Authors and Affiliations

UPENDRA C GALGATTE , PRAVIN D CHAUDHARI

Keywords

Related Articles

EVALUATION OF ANTIOXIDANT AND ANTIULCER ACTIVITY OF METHANOLIC EXTRACT OF GARDENIA GUMMIFERA L. IN RATS

ABSTRACTObjective: The aim was to assess the effect of anti ulcer and anti oxidant activity of methanolic extract of Gardenia Gummifera (MEGG) whole plant inulcer induced rats and in-vitro anti oxidants method respective...

OPTIMIZATION STUDY ON EXTRACTION & PURIFICATION OF PHYCOERYTHRIN FROM RED ALGAE KAPPAPHYCUS ALVAREZII

Objective: The current study focuses on R-Phycoerythrin pigment production from Seaweed using different chemical and physical conditions. Methods: In the present study Seaweed was collected from Rameshwaram and identifi...

MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS AUREUS IN A TERTIARY CARE HOSPITAL OF SOUTH INDIA – A PROSPECTIVE STUDY

Objective: Mupirocin is a topical antibiotic used for the treatment of skin and soft tissue infections caused by Staphylococcus aureus and for the nasal decolonization of methicillin-resistant S. aureus (MRSA). The incre...

A STUDY ON THE EFFECT OF DIETARY FACTORS ON FUNCTIONAL GASTROINTESTINAL DISORDERS IN WOMEN OF HA’IL REGION IN SAUDI ARABIA

Objective: The aim of this study is to assess the prevalence of functional gastrointestinal disorders (FGIDs) among the women population of the Ha’il region in Saudi Arabia. It also includes the analysis of the effect...

IN VIVO AMELIORATIVE POTENTIAL OF CAFFEIC ACID AGAINST HEPATOTOXICITY AND NEPHROTOXICITY INDUCED BY MERCURIC CHLORIDE IN ALBINO WISTAR RATS

Objective: The current experimental study is designed to scrutinize the possible defensive effect of caffeic acid (CA) against mercury-induced hepatotoxicity in male rats. Methods: During the treatment periods, a sub-le...

Download PDF file
  • EP ID EP604692
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

UPENDRA C GALGATTE, PRAVIN D CHAUDHARI (2019). DEVELOPMENT OF METOCLOPRAMIDE HYDROCHLORIDE IN SITU GEL: NASAL DELIVERY AND PHARMACOKINETICS IN NEW ZEALAND RABBITS. Asian Journal of Pharamceutical and Clinical Research, 12(4), 280-285. https://europub.co.uk/articles/-A-604692